Furthermore, ROS and TGF-β can cooperate in modulating inflammatory and immune response against cancer, thus creating a microtumor environment that benefits cancer cells, to survive and induce a resistance of the tumor cells to apoptosis and chemotherapy. This evidence concerns the gene TGFB1 and neoplasm.